Lower urinary tract symptoms (LUTS) in males: a review of pathophysiology

References

• Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.10.1002/(ISSN)1520-6777
   PubMed Web of Science ®Google Scholar
• Haider A, Gooren LJ, Padungtod P, et al. Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men. Andrologia. 2009;41:7–13.10.1111/and.2009.41.issue-1
   PubMed Web of Science ®Google Scholar
• Kwon H, Kang HC, Lee JH. Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms. Urology. 2013;81(6):1325–9.10.1016/j.urology.2013.01.042
   PubMed Web of Science ®Google Scholar
• Litman HJ, Steers WD, Wei JT, et al.. Relationship of Lifestyle and Clinical Factors to Lower Urinary Tract Symptoms: Results from Boston Area Community Health Survey. Urology. 2007;70(5):916–21.10.1016/j.urology.2007.06.1117
   PubMed Web of Science ®Google Scholar
• Favilla V, Cimino S, Castelli T, et al. Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia. BJU Int. 2010;106(11):1700–3.10.1111/bju.2010.106.issue-11
   PubMed Web of Science ®Google Scholar
• Vesely S, Knutson T, Damber J, et al. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2003;37:322–8.10.1080/00365590310014760
   PubMed Web of Science ®Google Scholar
• Moul S, McVary KT. Lower urinary tract symptoms, obesity and the metabolic syndrome. Curr Opin Urol. 2010;20(1):7–12.10.1097/MOU.0b013e3283336f3f
   PubMed Web of Science ®Google Scholar
• Irwin DE, Kopp ZS, Agatep B, et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108:1132–8.10.1111/bju.2011.108.issue-7
   PubMed Web of Science ®Google Scholar
• Goedecke JH, Jennings CL, Lambert EV. Obesity in South Africa. Chronic Dis lifestyle S Afr. 1995;2005(7):65–79.
   Google Scholar
• Wong SY, Woo J, Leung JC, et al. Depressive symptoms and lifestyle factors as risk factors of lower urinary tract symptoms in Southern Chinese men: a prospective study. Aging Male. 2010;13(2):113–9.10.3109/13685530903440432
   PubMed Web of Science ®Google Scholar
• Lu Z, Gao Y, Tan A, et al. Increased high-sensitivity C-reactive protein predicts a high risk of lower urinarytract symptoms in Chinese male results from the fangchenggang area male health and examination survey. Prostate. 2012;72:193–200.10.1002/pros.v72.2
   PubMed Web of Science ®Google Scholar
• Azam U, Castleden M, Turner D. Economics of lower urinary tract symptoms (LUTS) in older people. Drugs Aging. 2001;18(3):213–23.10.2165/00002512-200118030-00006
   PubMed Web of Science ®Google Scholar
• Çinar A, Hall SA, Link CA, et al. Cluster analysis and lower urinary tract symptoms in men: findings from the Boston area community health survey. N Eng Res Inst Inc. 2008;101:1247–56.
   Google Scholar
• Fowke JH, Munro HS, Signorello LB, et al. Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men. J Gen Intern Med. 2011;26(11):1305–10.10.1007/s11606-011-1776-8
   PubMed Web of Science ®Google Scholar
• Van Den Eeden SK, Shan J, Jacobsen SJ, et al. Evaluating racial/ethnic disparities in lower urinary tract symptoms in men. J Urol. 2012;187:185–9.10.1016/j.juro.2011.09.043
   PubMed Web of Science ®Google Scholar
• Penson DF, Munro HM, Signorello LB, et al. Obesity, physical activity and lower urinary tract symptoms: results from the southern community cohort study. J Urol. 2011;186(6):2316–22.10.1016/j.juro.2011.07.067
   PubMed Web of Science ®Google Scholar
• Chokkalingam AP, Yeboah ED, DeMarzo A, et al. Prevalence of BPH and lower urinary tract symptoms in West Africans. Prostate Cancer Prostatic Dis. 2012;15:170–6.10.1038/pcan.2011.43
   PubMed Web of Science ®Google Scholar
• Coyne KS, Kaplan SA, Chapple CR, et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int. 2009;103(3):24–32.10.1111/bju.2009.103.issue-s3
   PubMed Web of Science ®Google Scholar
• Laven BA, Orsini N, Andersson SO, et al. Birth weight, abdominal obesity and the risk of lower urinary tract symptoms in a population based study of Swedish men. J Urol. 2008;179(5):1891–6.10.1016/j.juro.2008.01.029
   PubMed Web of Science ®Google Scholar
• DeLancey J, Gosling J, Creed K, et al. Gross anatomy and cell biology of the lower urinary tract. In: Abrams P, Cardozo L, Khoury S, et al., editors. Incontinence. Plymouth: Health Publication; 2002. p. 19–82.
   Google Scholar
• Birder LA, de Groat WC. Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pract Urol. 2007;4(1):46–54.10.1038/ncpuro0672
   PubMedGoogle Scholar
• Yassin A, Saad F, Hoesl CE, et al. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS – implications for clinical practice. Andrologia. 2006;38:1–12.10.1111/and.2006.38.issue-1
   PubMed Web of Science ®Google Scholar
• Ho CKM, Habib FK. Estrogen and androgen signaling in the pathogenesis of BPH. Nat Rev Urol. 2011;8(1):29–41.10.1038/nrurol.2010.207
   PubMed Web of Science ®Google Scholar
• Rodriguez-Nieves JA, Macoska JA. Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nat Rev Urol. 2013;10(9):546–50.10.1038/nrurol.2013.149
   PubMed Web of Science ®Google Scholar
• Litman HJ, Bhasin S, O’Leary MP, et al. An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston area community health survey. BJU Int. 2007;100(2):321–6.10.1111/bju.2007.100.issue-2
   PubMed Web of Science ®Google Scholar
• Nandeesha H. Benign prostatic hyperplasia: dietary and metabolic risk factors. Int Urol Nephrol. 2008;40(3):649–56.10.1007/s11255-008-9333-z
   PubMed Web of Science ®Google Scholar
• Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol. 2007;178(2):395–401.10.1016/j.juro.2007.03.103
   PubMed Web of Science ®Google Scholar
• Parsons JK, Sarma AV, McVary K, et al. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol. 2013;189(1):S102–6.10.1016/j.juro.2012.11.029
   Google Scholar
• Lu Z, Gao Y, Tan A, et al. Increased high-sensitivity c-reactive protein predicts a high risk of lower urinary tract symptoms in Chinese male: Results from the fangchenggang area male health and examination survey. Prostate. 2012;72(2):193–200.10.1002/pros.v72.2
   PubMed Web of Science ®Google Scholar
• Moul S, McVary KT. Lower urinary tract symptoms, obesity and the metabolic syndrome. Curr Opin Urol. 2010;20(1):7–12.10.1097/MOU.0b013e3283336f3f
   PubMed Web of Science ®Google Scholar
• Kasturi S, Russell S, McVary KT. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep. 2006;7:288–92.10.1007/s11934-996-0008-y
   PubMedGoogle Scholar
• Rohrmann S, Smit E, Giovannucci E, et al. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the third national health and nutrition examination survey (NHANES III). Int J Obes. 2005;29:310–6.10.1038/sj.ijo.0802881
   PubMed Web of Science ®Google Scholar
• Demir O, Akgul K, Akar Z, et al. Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome. Aging Male. 2009;12(1):29–34.10.1080/13685530902777425
   PubMed Web of Science ®Google Scholar
• Joseph MA, Harlow DS, Wel JT, et al. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol. 2003;157(10):906–14.10.1093/aje/kwg051
   PubMed Web of Science ®Google Scholar
• Rohrmann S, Crespot CJ, Weber JR, et al. Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey. BJU Int. 2005;96:77–82.
   PubMed Web of Science ®Google Scholar
• Wang S, Mao Q, Lin Y, et al. Body mass index and risk of BPH: a meta-analysis. Prostate Cancer Prostatic Dis. 2011;15(3):265–72.
   PubMed Web of Science ®Google Scholar
• Hammarsten J, Peeker R. Urological aspects of the metabolic syndrome. Nat Rev Urol. 2011;8(9):483–94.10.1038/nrurol.2011.112
   PubMed Web of Science ®Google Scholar
• Morandi A, Maffeis C. Urogenital complications of obesity. Best Pract Res Clin Endocrinol Metabol. 2013;27:209–18.
   PubMed Web of Science ®Google Scholar
• Khoo J, Piantadosi C, Worthley S, et al. Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men. Int J Obes. 2010;34:1396–403.10.1038/ijo.2010.76
   PubMed Web of Science ®Google Scholar
• Lee RK, Chung D, Chughtai B, et al. Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms. BJU Int. 2012;110(4):540–5.10.1111/bju.2012.110.issue-4
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim JC, Lee JY, et al. Effects of components of metabolic syndrome on sexual function in Korean BPH/LUTS patients. J Sex Med. 2009;6(8):2292–8.10.1111/jsm.2009.6.issue-8
   PubMed Web of Science ®Google Scholar
• Aktas BK, Gokkaya CS, Bulut S, et al. Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients. Aging Male. 2011;14(1):48–52.10.3109/13685538.2010.529197
   PubMed Web of Science ®Google Scholar
• Ozden C, Ozdal OL, Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol. 2007;51(1):199–206.10.1016/j.eururo.2006.05.040
   PubMed Web of Science ®Google Scholar
• Wallner LP, Hollingsworth JM, Dunn RL, et al. Hyperglycemia, hyperinsulinemia, insulin resistance, and the risk of BPH/LUTS severity and progression over time in community dwelling black men: the Flint men’s health study. Urology. 2013;82(4):881–6.10.1016/j.urology.2013.05.034
   PubMed Web of Science ®Google Scholar
• McVary KT, Rademaker A, Lloyd GL, et al. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2005;174(4):1327–33.10.1097/01.ju.0000173072.73702.64
   PubMed Web of Science ®Google Scholar
• Milani S, Djavan B. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha1-adrenoceptor antagonists. BJU Int. 2005;95(s4):29–36.10.1111/bju.2005.95.issue-s4
   PubMed Web of Science ®Google Scholar
• McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int. 2006;97(s2):23–8.10.1111/bju.2006.97.issue-s2
   PubMed Web of Science ®Google Scholar
• Eom CS, Park JH, Cho BL, et al. Metabolic syndrome and accompanying hyperinsulinemia have favorable effects on lower urinary tract symptoms in a generally healthy screened population. J Urol. 2011;186:175–9.10.1016/j.juro.2011.03.025
   PubMed Web of Science ®Google Scholar
• Park YW, Min SK, Lee JH. Relationship between lower urinary tract symptoms/benign prostatic hyperplasia and metabolic syndrome in Korean men. World J Mens Health. 2012;30(3):183–8.10.5534/wjmh.2012.30.3.183
   PubMedGoogle Scholar
• Tewari R, Prabhat P, Natu S, et al. Association of benign prostatic hyperplasia (BPH) with the metabolic syndrome (MS) and its components – ‘a growing dilemma’. J Men’s Health. 2011;8(1):66–71.10.1016/j.jomh.2010.09.231
   Web of Science ®Google Scholar
• Rohrmann S, Smit E, Giovannucci E, et al. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the third national health and nutrition examination survey (NHANES III). Int J Obes. 2005;29(3):310–6.10.1038/sj.ijo.0802881
   PubMed Web of Science ®Google Scholar
• Hammarsten J, Peeker R. Urological aspects of the metabolic syndrome. Nat Rev Urol. 2011;8(9):483–94.10.1038/nrurol.2011.112
   PubMed Web of Science ®Google Scholar
• Tomita K, Mizoue T, Matsumoto T. Lower urinary tract symptoms in relation to lifestyle and medical conditions in Japanese workers. Int J Urol. 2009;16:493–8.10.1111/j.1442-2042.2009.02276.x
   PubMed Web of Science ®Google Scholar
• Coyne KS, Kaplan SA, Chapple CR, et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int. 2009;103(3):24–32.10.1111/bju.2009.103.issue-s3
   PubMed Web of Science ®Google Scholar
• Wang CC, Chancellor MB, Lin JM, et al. Type 2 diabetes but not metabolic syndrome is associated with an increased risk of lower urinary tract symptoms and erectile dysfunction in men aged <45 years. BJU Int. 2010;105(8):1136–40.10.1111/bju.2010.105.issue-8
   PubMed Web of Science ®Google Scholar
• Seim A, Hoyo C, Ostbye T, et al. The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study. BJU Int. 2005;96:88–92.10.1111/bju.2005.96.issue-1
   PubMed Web of Science ®Google Scholar
• Kaplan SA, Roehrborn CG, Chapple CR, et al. Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms. BJU Int. 2009;103(3):48–57.10.1111/bju.2009.103.issue-s3
   PubMed Web of Science ®Google Scholar
• Kupelian V, McVary KT, Kaplan SA, et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey. J Urol. 2009;182(2):616–25.10.1016/j.juro.2009.04.025
   PubMed Web of Science ®Google Scholar
• Martin S, Lange K, Haren MT, et al. Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men. J Urol. 2014;191(1):130–7.10.1016/j.juro.2013.06.018
   PubMed Web of Science ®Google Scholar